Results 61 to 70 of about 744 (160)

FORMULATION AND INVITRO EVALUATION OF BUCCAL FILMS OF BISOPROLOL FUMARATE

open access: yes, 2019
Bisoprolol is a drug belonging to the group of beta-blockers, a class of medicines used primarily in cardiovascular diseases. More specifically, it is a selective type β1 adrenergic receptor blocker. The U.S. Food and Drug Administration (FDA) approved an application by Duramed Pharmaceutical for Zebeta Oral Tablets (bisoprolol fumarate) as a new ...
openaire   +2 more sources

Overview on Analytical Methods for Simultaneous Estimation of Bisoprolol Fumarate and Telmisartan

open access: yesInternational Journal For Multidisciplinary Research
This article reviews the development and validation of High-Performance Liquid Chromatography (HPLC) methods, particularly Reverse Phase HPLC (RP-HPLC), for the simultaneous estimation of Bisoprolol fumarate and Telmisartan in pharmaceutical formulations.
Anjali Patel -   +3 more
openaire   +1 more source

Analysis of related substances in bisoprolol fumarate on sub-2-μm adsorbents

open access: yesActa Chromatographica, 2012
Summary The new analytical method of very high pressure liquid chromatography (VHPLC) has been designed for the estimation of related substances in bisoprolol fumarate. Several columns filled with sub-2-μm totally porous and shell adsorbent have been tested and compared during the method development. The columns' resolution was investigated.
M. Szalka   +3 more
openaire   +1 more source

Investigation of Metoprolol Concentrations in Plasma Using Automated Sample Preparation and LC-MS/MS Detection

open access: yesSeparations
Metoprolol (MTP), a selective beta-1 adrenergic blocker, is commonly administered in the form of succinate or tartrate salts, depending on the pharmaceutical formulation.
Ionel-Bogdan Cioroiu   +4 more
doaj   +1 more source

UEG Week 2025 Poster Presentations

open access: yes
United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source

MICROENCAPSULATION BISOPROLOL FUMARATE WITH EUDRAGIT E PO BY SOLVENT EVAPORATION METHOD

open access: yesInternational Journal of Applied Pharmaceutics
Objective: This study aimed to develop and optimize the microcapsule formula of bisoprolol fumarate-Eudragit EPO by double-emulsion solvent evaporation. Methods: The preparation of bisoprolol fumarate-Eudragit EPO microcapsule was done in three different ratios 1: 3 (F1), 1: 4 (F2), and 1: 5 (F3), followed by characterization of each of the ...
AZHOMA GUMALA   +3 more
openaire   +1 more source

Research on the optimization of the composition and technology of combined tablets of bisoprolol fumarate with indapamide

open access: yesScienceRise: Pharmaceutical Science
Мета. Розробка та оптимізація складу таблеток, що містять бісопрололу фумарат з індапамідом, з використанням методології поверхні відгуку (в програмному забезпеченні Design-Expert) для отримання кінцевої лікарської форми з необхідними фармако-технологічними і біофармацевтичними характеристиками.
Nadia Malanchuk, Mariana Demchuk
openaire   +3 more sources

A case of reinitiation of modified electroconvulsive therapy 2 weeks after modified electroconvulsive therapy‐induced Takotsubo cardiomyopathy in a male patient with major depressive disorder

open access: yesPCN Reports
Background Takotsubo cardiomyopathy (TCM) is a left ventricular dysfunction resembling acute coronary syndrome. Its prognosis is generally favorable; however, a subset of patients may present with severe complications.
Dai Kezuka   +3 more
doaj   +1 more source

Dual-platform integration of HPTLC and firefly algorithm-optimized chemometrics with hammersley sequence sampling for simultaneous quantification of bisoprolol, amlodipine, and mutagenic impurity 4-hydroxybenzaldehyde

open access: yesBMC Chemistry
The simultaneous quantification of active pharmaceutical ingredients alongside their mutagenic impurities represents a critical challenge in pharmaceutical quality control.
Lateefa A. Al-Khateeb   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy